Condition: Pancreatic Cancer · Pancreas Disease · Pancreatic Cyst · Sponsor: Orlando Health, Inc.
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
This description comes directly from the study's public registry record.
Shyam Varadarajulu, MD · 321-841-2431 · shyam.varadarajulu@orlandohealth.com
Barbara Broome · 321-841-4356 · barbara.broome@orlandohealth.com
Always discuss trial participation with your own doctor first.
| Orlando Health | Orlando, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06564571